NCT06266221View on ClinicalTrials.gov

Severe Erythema Multiforme - CORTICO

PHASE3Not yet recruitingINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

May 1, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

November 1, 2027

Conditions

Erythema Multiforme

Interventions

DRUG

Prednisone 20 Mg

Oral corticosteriods

DRUG

Oral Placebo

Oral placebo

DRUG

Methylprednisolone 120 Mg

IV corticosteriods

DRUG

IV Placebo

IV placebo

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER